190 related articles for article (PubMed ID: 23950960)
1. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.
Iwasaki J; Smith WA; Stone SR; Thomas WR; Hales BJ
PLoS One; 2013; 8(8):e70552. PubMed ID: 23950960
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection.
Iwasaki J; Smith WA; Khoo SK; Bizzintino J; Zhang G; Cox DW; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
J Allergy Clin Immunol; 2014 Jul; 134(1):25-32. PubMed ID: 24767874
[TBL] [Abstract][Full Text] [Related]
3. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.
Gaido CM; Stone S; Chopra A; Thomas WR; Le Souëf PN; Hales BJ
J Virol; 2016 Dec; 90(23):10459-10471. PubMed ID: 27630239
[TBL] [Abstract][Full Text] [Related]
4. Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms.
Niespodziana K; Cabauatan CR; Jackson DJ; Gallerano D; Trujillo-Torralbo B; Del Rosario A; Mallia P; Valenta R; Johnston SL
EBioMedicine; 2015 Jan; 2(1):64-70. PubMed ID: 26137535
[TBL] [Abstract][Full Text] [Related]
5. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections.
Niespodziana K; Napora K; Cabauatan C; Focke-Tejkl M; Keller W; Niederberger V; Tsolia M; Christodoulou I; Papadopoulos NG; Valenta R
FASEB J; 2012 Mar; 26(3):1001-8. PubMed ID: 22121050
[TBL] [Abstract][Full Text] [Related]
6. Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations.
Iwasaki J; Chai LY; Khoo SK; Bizzintino J; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
Clin Exp Allergy; 2015 Oct; 45(10):1523-30. PubMed ID: 25640320
[TBL] [Abstract][Full Text] [Related]
7. Rhinovirus-specific antibody responses in preschool children with acute wheeze reflect severity of respiratory symptoms.
Stenberg-Hammar K; Niespodziana K; Söderhäll C; James A; Cabauatan CR; Konradsen JR; Melén E; van Hage M; Valenta R; Hedlin G
Allergy; 2016 Dec; 71(12):1728-1735. PubMed ID: 27444786
[TBL] [Abstract][Full Text] [Related]
8. Proposals for the classification of human rhinovirus species C into genotypically assigned types.
Simmonds P; McIntyre C; Savolainen-Kopra C; Tapparel C; Mackay IM; Hovi T
J Gen Virol; 2010 Oct; 91(Pt 10):2409-19. PubMed ID: 20610666
[TBL] [Abstract][Full Text] [Related]
9. Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1.
McLean GR; Walton RP; Shetty S; Peel TJ; Paktiawal N; Kebadze T; Gogsadze L; Niespodziana K; Valenta R; Bartlett NW; Johnston SL
Antiviral Res; 2012 Sep; 95(3):193-201. PubMed ID: 22742898
[TBL] [Abstract][Full Text] [Related]
10. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
11. Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.
Warner S; Hartley CA; Stevenson RA; Ficorilli N; Varrasso A; Studdert MJ; Crabb BS
J Virol; 2001 Oct; 75(19):9274-81. PubMed ID: 11533189
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genetic diversity and sites of recombination in human rhinovirus species C.
McIntyre CL; McWilliam Leitch EC; Savolainen-Kopra C; Hovi T; Simmonds P
J Virol; 2010 Oct; 84(19):10297-310. PubMed ID: 20668080
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
Katpally U; Fu TM; Freed DC; Casimiro DR; Smith TJ
J Virol; 2009 Jul; 83(14):7040-8. PubMed ID: 19403680
[TBL] [Abstract][Full Text] [Related]
14. Rhinovirus genome evolution during experimental human infection.
Cordey S; Junier T; Gerlach D; Gobbini F; Farinelli L; Zdobnov EM; Winther B; Tapparel C; Kaiser L
PLoS One; 2010 May; 5(5):e10588. PubMed ID: 20485673
[TBL] [Abstract][Full Text] [Related]
15. Modeling of the human rhinovirus C capsid suggests a novel topography with insights on receptor preference and immunogenicity.
Basta HA; Sgro JY; Palmenberg AC
Virology; 2014 Jan; 448():176-84. PubMed ID: 24314648
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children.
Chen WJ; Arnold JC; Fairchok MP; Danaher PJ; McDonough EA; Blair PJ; Garcia J; Halsey ES; Schofield C; Ottolini M; Mor D; Ridoré M; Burgess TH; Millar EV
J Clin Virol; 2015 Mar; 64():74-82. PubMed ID: 25728083
[TBL] [Abstract][Full Text] [Related]
17. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation.
Edlmayr J; Niespodziana K; Popow-Kraupp T; Krzyzanek V; Focke-Tejkl M; Blaas D; Grote M; Valenta R
Eur Respir J; 2011 Jan; 37(1):44-52. PubMed ID: 20530036
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.
Jacobs SE; Lamson DM; Soave R; Guzman BH; Shore TB; Ritchie EK; Zappetti D; Satlin MJ; Leonard JP; van Besien K; Schuetz AN; Jenkins SG; George KS; Walsh TJ
J Clin Virol; 2015 Oct; 71():51-8. PubMed ID: 26370315
[TBL] [Abstract][Full Text] [Related]
19. [Human rhinovirus with different genotypes in children with acute respiratory tract infections in Beijing].
Song MH; Zhao LQ; Qian Y; Zhu RN; Deng J; Wang F; Sun Y; Tian R
Bing Du Xue Bao; 2013 Mar; 29(2):97-105. PubMed ID: 23757837
[TBL] [Abstract][Full Text] [Related]
20. A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro.
Behzadi MA; Choi A; Duehr J; Feyznezhad R; Upadhyay C; Schotsaert M; Palese P; Nachbagauer R
Sci Rep; 2020 Jun; 10(1):9750. PubMed ID: 32546721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
